Stargardt Disease Therapeutics involves the treatment of the central retina along with the intake of vitamin A-deficit diet
Stagardt disease is
an uncommon autoimmune disease that primarily affects the skin. It commonly
presents as a scaly red lesion that appears on the eyelid, behind the ear, or
in the mouth. The disease typically affects children, and most cases can be
treated with topical eye drops, rashes, or oral medications. No rigorous blood
tests must be performed to determine the presence of the disease. Since the
symptoms can also mimic other eye diseases, it is important that an appropriate
testing protocol be followed for each patient.
Stargardt disease is
an autoimmune disorder that results in scarring in the intestines. When this
scarring occurs, it blocks the passage of nutrients and waste materials from
the small intestine to the colon. This can result in constipation, diarrhea,
and other bowel problems. Stargardt
disease therapeutics include removing the scar as well as using a drug
to encourage the growth of healthy cells and fibers in the gut wall and
intestine walls.
Currently, there are
several clinical trials taking place to test the safety and efficacy of a new
drug specifically formulated to prevent Stargardt disease. For instance, in June 2020, according to a study from the U.S. National
Center for Biotechnology Information (NCBI), over-consumption of vitamin A was
found to be a potential cause for the severity of Stargardt disease and
patients were recommended to avoid vitamin A supplements. A clinical trial
evaluating the combination of these two drugs is currently undergoing
enrollment and will conclude with a report detailing the results. If the
results of the clinical trial are positive, then the two drugs could be approved
as a single medicine under the authority of the U.S. Food and Drug
Administration (FDA).
Another treatment
option being considered by investigators is embryo transfer. This is another
option that has been controversial due to its high success rates. The
investigators have, however, determined that there is a high probability of
this treatment being effective for patients suffering from Stargardt disease.
These are only a few of the Stargardt disease therapeutics and embryo transfer
candidates being studied.
Comments
Post a Comment